Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kanfer

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|November 12, 1988
Thalidomide for graft-versus-host diseaseD M McCarthy, E Kanfer, J Taylor, et al.
British Journal of Haematology|December 1, 1992
Erythropoietin-independent colony growth in polycythaemia vera is not restricted to progenitor cells with trisomy of chromosome 8E Kanfer, C M Price, S M Colman, et al.
Cancer Genetics and Cytogenetics|February 1, 1989
An unusual t(9;12)(p13;q24) in childhood acute lymphocytic leukemiaC Price, D Hagger, E Kanfer, et al.
Bone Marrow Transplantation|October 23, 1997
CD34 counts to predict the adequate collection of peripheral blood progenitor cellsS Armitage, R Hargreaves, D Samson, et al.
Bone Marrow Transplantation|March 1, 1988
Q fever following bone marrow transplantationE Kanfer, N Farrag, C Price, et al.
Bone Marrow Transplantation|January 1, 1989
Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remissionA J Barrett, M M Horowitz, D M McCarthy, et al.
British Journal of Haematology|May 3, 2000
High-dose busulphan alone as cytoreduction before allogeneic or autologous stem cell transplantation for chronic myeloid leukaemia: a single-centre experienceE Olavarria, E Kanfer, R Szydlo, et al.
Bone Marrow Transplantation|April 28, 1999
A comparison of prophylactic vs pre-emptive ganciclovir to prevent cytomegalovirus disease after T-depleted volunteer unrelated donor bone marrow transplantationR Stocchi, R Szydlo, C Craddock, et al.
Histopathology|June 27, 2007
Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patientsF Amen, D Horncastle, K Elderfield, et al.
Leukemia|November 9, 2000
A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantationE Olavarria, M Hassan, A Eades, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|November 12, 1988
Thalidomide for graft-versus-host diseaseD M McCarthy, E Kanfer, J Taylor, et al.
British Journal of Haematology|December 1, 1992
Erythropoietin-independent colony growth in polycythaemia vera is not restricted to progenitor cells with trisomy of chromosome 8E Kanfer, C M Price, S M Colman, et al.
Cancer Genetics and Cytogenetics|February 1, 1989
An unusual t(9;12)(p13;q24) in childhood acute lymphocytic leukemiaC Price, D Hagger, E Kanfer, et al.
Bone Marrow Transplantation|October 23, 1997
CD34 counts to predict the adequate collection of peripheral blood progenitor cellsS Armitage, R Hargreaves, D Samson, et al.
Bone Marrow Transplantation|March 1, 1988
Q fever following bone marrow transplantationE Kanfer, N Farrag, C Price, et al.
Bone Marrow Transplantation|January 1, 1989
Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remissionA J Barrett, M M Horowitz, D M McCarthy, et al.
British Journal of Haematology|May 3, 2000
High-dose busulphan alone as cytoreduction before allogeneic or autologous stem cell transplantation for chronic myeloid leukaemia: a single-centre experienceE Olavarria, E Kanfer, R Szydlo, et al.
Bone Marrow Transplantation|April 28, 1999
A comparison of prophylactic vs pre-emptive ganciclovir to prevent cytomegalovirus disease after T-depleted volunteer unrelated donor bone marrow transplantationR Stocchi, R Szydlo, C Craddock, et al.
Histopathology|June 27, 2007
Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patientsF Amen, D Horncastle, K Elderfield, et al.
Leukemia|November 9, 2000
A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantationE Olavarria, M Hassan, A Eades, et al.
Pageof 4